Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kacper Boroń

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
The American Journal of Case Reports|January 22, 2026
Management of Bartholin's Gland Carcinoma in a Perimenopausal Woman: A Case ReportPrzemysław Borawski, Robert Kulhawik, Dariusz Boroń, et al.
Frontiers in Oncology|June 1, 2026
Systemic dysregulation of essential and toxic elements and redox homeostasis in gynecologic malignanciesPaweł Ordon, Kacper Boroń, Krzysztof Bereza, et al.
Cell Cycle (Georgetown, Tex.)|July 28, 2022
Effects of Cyclosporine A and Adalimumab on the expression profiles histaminergic system-associated genes and microRNAs regulating these genes in HaCaT cellsTomasz Kasela, Maciej Dąbala, Magdalena Mistarz, et al.
Cancers|April 14, 2026
Assessment of Essential and Toxic Element Levels in Endometrial and Ovarian CancerPaweł Ordon, Kacper Boroń, Krzysztof Bereza, et al.
Frontiers in Oncology|January 24, 2025
Distinct mRNA expression profiles and miRNA regulators of the PI3K/AKT/mTOR pathway in breast cancer: insights into tumor progression and therapeutic targetsTomasz Sirek, Katarzyna Król-Jatręga, Przemysław Borawski, et al.
Frontiers in Oncology|April 23, 2025
Corrigendum: Distinct mRNA expression profiles and miRNA regulators of the PI3K/AKT/mTOR pathway in breast cancer: insights into tumor progression and therapeutic targetsTomasz Sirek, Katarzyna Król-Jatręga, Przemysław Borawski, et al.
Biomedicines|October 26, 2024
Evaluation of Selenium Concentrations in Patients with Crohn's Disease and Ulcerative ColitisMichał Chalcarz, Beniamin Oskar Grabarek, Tomasz Sirek, et al.
Breast Cancer Research and Treatment|May 27, 2025
Subtype-specific dysregulation of biogenic amine-related genes and miRNAs in breast cancer: identification of DRD2, HRH2, and HRH4 as potential therapeutic targets in TNBC and HER2+ subtypesAgata Sirek, Tomasz Sirek, Robert Nowakowski, et al.
Biomedicines|December 30, 2025
Subtype-Independent Dysregulation of the Notch Signaling Pathway and Its miRNA Regulators in Breast CancerElżbieta Mitka-Krysiak, Katarzyna Król-Jatręga, Piotr Ossowski, et al.
Frontiers in Molecular Biosciences|March 20, 2026
Integrated transcriptomic, protein, and MicroRNA profiling reveals a conserved pyroptosis-related molecular signature across breast cancer subtypesAgata Panfil, Tomasz Sirek, Agata Sirek, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The American Journal of Case Reports|January 22, 2026
Management of Bartholin's Gland Carcinoma in a Perimenopausal Woman: A Case ReportPrzemysław Borawski, Robert Kulhawik, Dariusz Boroń, et al.
Frontiers in Oncology|June 1, 2026
Systemic dysregulation of essential and toxic elements and redox homeostasis in gynecologic malignanciesPaweł Ordon, Kacper Boroń, Krzysztof Bereza, et al.
Cell Cycle (Georgetown, Tex.)|July 28, 2022
Effects of Cyclosporine A and Adalimumab on the expression profiles histaminergic system-associated genes and microRNAs regulating these genes in HaCaT cellsTomasz Kasela, Maciej Dąbala, Magdalena Mistarz, et al.
Cancers|April 14, 2026
Assessment of Essential and Toxic Element Levels in Endometrial and Ovarian CancerPaweł Ordon, Kacper Boroń, Krzysztof Bereza, et al.
Frontiers in Oncology|January 24, 2025
Distinct mRNA expression profiles and miRNA regulators of the PI3K/AKT/mTOR pathway in breast cancer: insights into tumor progression and therapeutic targetsTomasz Sirek, Katarzyna Król-Jatręga, Przemysław Borawski, et al.
Frontiers in Oncology|April 23, 2025
Corrigendum: Distinct mRNA expression profiles and miRNA regulators of the PI3K/AKT/mTOR pathway in breast cancer: insights into tumor progression and therapeutic targetsTomasz Sirek, Katarzyna Król-Jatręga, Przemysław Borawski, et al.
Biomedicines|October 26, 2024
Evaluation of Selenium Concentrations in Patients with Crohn's Disease and Ulcerative ColitisMichał Chalcarz, Beniamin Oskar Grabarek, Tomasz Sirek, et al.
Breast Cancer Research and Treatment|May 27, 2025
Subtype-specific dysregulation of biogenic amine-related genes and miRNAs in breast cancer: identification of DRD2, HRH2, and HRH4 as potential therapeutic targets in TNBC and HER2+ subtypesAgata Sirek, Tomasz Sirek, Robert Nowakowski, et al.
Biomedicines|December 30, 2025
Subtype-Independent Dysregulation of the Notch Signaling Pathway and Its miRNA Regulators in Breast CancerElżbieta Mitka-Krysiak, Katarzyna Król-Jatręga, Piotr Ossowski, et al.
Frontiers in Molecular Biosciences|March 20, 2026
Integrated transcriptomic, protein, and MicroRNA profiling reveals a conserved pyroptosis-related molecular signature across breast cancer subtypesAgata Panfil, Tomasz Sirek, Agata Sirek, et al.
Pageof 2